19 September 2023
19 September 2023
The Clinical Trials Arena team also reviews assets genetic disorders and metabolic disorders indications.
The company plans to refile the IND after assessing the feasibility of US FDA-suggested trial modifications.
The IZERVAY monthly dosing regimen met the primary objective of reducing the GA growth against sham, at 24 months.
Aclaris is planning to commence a Phase IIa proof-of-concept trial of ATI-2138 in patients with ulcerative colitis.
Embattled biotech giant Illumina has led series A funding into genomics mapping company Broken String Biosciences.
The company announced positive topline results from the single-ascending dose stage 1 portion of the study earlier this year.
The trial includes dose escalation and expansion studies of BBI-355 along with certain selected targeted therapies.
The ‘Emma’ twin will document its participation in device and drug trials on social media.
The Excellence Awards celebrate the greatest achievements and innovations in the industry, and the people and companies that are driving change.
The success of CAR-Ts in MM has fueled R&D investment into this class of therapy, with more CAR-Ts in development than all other cell and gene therapy classes combined. The approval of the autologous CAR-T cell therapies Abecma and Carvykti sees the CAR-T pipeline mostly constituted of autologous drugs. However, there are also multiple allogeneic CAR-Ts in the pipeline, with these therapies having an “off-the-shelf” advantage over autologous therapies.
Give your business an edge with our leading industry insights.
